Literature DB >> 14719216

Comparing the self-reported referral and management preferences of pediatricians and family physicians for children with juvenile rheumatoid arthritis.

Gary L Freed1, Sandra Jee, Leonard Stein, Laura Spera, Sarah J Clark.   

Abstract

OBJECTIVE: The symptoms of juvenile rheumatoid arthritis (JRA) are often first recognized by primary care physicians. Little is known about the determinants of the initial management and referral patterns of these physicians for children with JRA. We compared the self-reported preferences and practices of pediatricians (PD) and family physicians (FP) in the diagnosis and management of children with JRA.
METHODS: Surveys were mailed to a national random sample of 700 PD and 867 FP. Questions included prior experience with JRA, usual patterns in the diagnosis and management of JRA, perception of the need for guidelines for referral and management of this condition, and physician demographic information. Data analysis included univariate and bivariate analysis.
RESULTS: Response rates were 69% for PD and 49% for FP. Most respondents had seen very few JRA cases in the previous 5 years. Only 1% of respondents reported that they provided all diagnosis and management for patients with JRA. Forty-two percent of PD and 32% of FP refer all JRA diagnosis and management to subspecialists, while 46% of PD and 61% of FP refer only to confirm the diagnosis and guide initial therapy (p = 0.011). More PD than FP (PD 92% vs FP 76%; p = 0.001) referred patients with JRA to pediatric rheumatologists, while more FP than PD referred to general rheumatologists (PD 17% vs FP 37%; p = 0.001). The majority of FP reported feeling more comfortable managing rheumatologic disease in adults than children (82%). Few respondents felt that they were up to date on the latest advances in JRA treatment (PD 10% vs FP 4%; p = 0.024).
CONCLUSION: Multiple factors may contribute to physicians' referral practice, including a patient's clinical status and the physician's beliefs of inadequacy of training and inability to stay up to date. The pattern of care that children with JRA receive likely will be influenced by initial presentation to a PD or to a FP.

Entities:  

Mesh:

Year:  2003        PMID: 14719216

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database.

Authors:  J M Burnham; J Shults; R Weinstein; J D Lewis; M B Leonard
Journal:  Ann Rheum Dis       Date:  2006-04-20       Impact factor: 19.103

Review 2.  Medical education in pediatric rheumatology-unique challenges and opportunities.

Authors:  Hemalatha Srinivasalu; Meredith Riebschleger
Journal:  Clin Rheumatol       Date:  2019-08-23       Impact factor: 2.980

3.  Prescribing for Children With Rheumatic Disease: Perceived Treatment Approaches Between Pediatric and Adult Rheumatologists.

Authors:  Heather van Mater; Stephen J Balevic; Gary L Freed; Sarah J Clark
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-02       Impact factor: 4.794

4.  Employment of a needs assessment survey to shape a novel web-based pediatric rheumatology curriculum for primary care providers.

Authors:  Amy Louise Woodward; Zena Leah Harris
Journal:  Pediatr Rheumatol Online J       Date:  2013-06-05       Impact factor: 3.054

5.  Barriers and alternatives to pediatric rheumatology referrals: survey of general pediatricians in the United States.

Authors:  Colleen K Correll; Logan G Spector; Lei Zhang; Bryce A Binstadt; Richard K Vehe
Journal:  Pediatr Rheumatol Online J       Date:  2015-07-29       Impact factor: 3.054

6.  Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type.

Authors:  Meredith P Riebschleger; Heather A Van Mater; Lisa M Cohn; Sarah J Clark
Journal:  Pediatr Rheumatol Online J       Date:  2014-09-05       Impact factor: 3.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.